Insider Stock Trading History of Ryan Arthur F


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Ryan Arthur F since year 2005. The trader's CIK number is 1187443. At the time of this reporting, Ryan Arthur F is the Director of Regeneron Pharmaceuticals Inc . (stock ticker symbol REGN). See this page for all insider trading activities at Regeneron Pharmaceuticals Inc .

Note that in the past RYAN ARTHUR F also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Ryan Arthur F since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2016-11-15 REGN Regeneron Pharmaceuticals Inc Sale 2,000 429.34 858,680
2016-05-24 REGN Regeneron Pharmaceuticals Inc Sale 1,000 396.64 396,640
2015-02-20 REGN Regeneron Pharmaceuticals Inc Option Ex 29,250 135.50 3,963,521
2015-02-20 REGN Regeneron Pharmaceuticals Inc Sale 29,250 423.03 12,373,686
2014-09-29 CFG Citizens Financial Group Inc/ri Buy 45,000 21.50 967,500
2013-08-22 REGN Regeneron Pharmaceuticals Inc Option Ex 30,000 33.39 1,001,640
2013-08-23 REGN Regeneron Pharmaceuticals Inc Sale 10,958 238.47 2,613,154
2013-05-31 REGN Regeneron Pharmaceuticals Inc Sale 2,500 249.51 623,787
2012-12-28 UBPS Universal Business Payment Solutions Acquisition Corp Sale 20,953 .01 167
2012-11-01 REGN Regeneron Pharmaceuticals Inc Sale 10,000 145.57 1,455,700
2012-10-01 UBPS Universal Business Payment Solutions Acquisition Corp Buy 1,000 6.05 6,050
2012-08-10 REGN Regeneron Pharmaceuticals Inc Sale 10,000 136.15 1,361,500
2012-01-12 REGN Regeneron Pharmaceuticals Inc Sale 25,500 78.97 2,013,862
2011-09-14 REGN Regeneron Pharmaceuticals Inc Option Ex 115,000 18.44 2,120,370
2010-06-14 REGN Regeneron Pharmaceuticals Inc Buy 10,000 26.98 269,800

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ryan Arthur F (Director of Regeneron Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.